Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
3.210
-0.270 (-7.76%)
At close: Dec 5, 2025, 4:00 PM EST
3.220
+0.010 (0.31%)
After-hours: Dec 5, 2025, 7:55 PM EST
Acurx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -9.17 | -14.1 | -14.58 | -12.09 | -12.75 | -4.6 | |
| Stock-Based Compensation | 1.73 | 3.44 | 3.77 | 3.3 | 6.07 | 1.48 | |
| Other Operating Activities | - | - | - | - | 1.52 | 0.57 | |
| Change in Accounts Payable | -0.44 | 0.2 | 0.98 | 1.22 | 0.39 | -0.8 | |
| Change in Other Net Operating Assets | 0.02 | 0.08 | 0.03 | 0.03 | -0.25 | -0 | |
| Operating Cash Flow | -7.85 | -10.38 | -9.8 | -7.54 | -5.01 | -3.35 | |
| Long-Term Debt Issued | - | - | - | - | - | 0.07 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | 0.07 | |
| Issuance of Common Stock | 8 | 6.62 | 8.16 | 3.7 | 14.8 | 3.98 | |
| Financing Cash Flow | 8 | 6.62 | 8.16 | 3.7 | 14.8 | 4.04 | |
| Net Cash Flow | 0.14 | -3.77 | -1.64 | -3.85 | 9.78 | 0.69 | |
| Levered Free Cash Flow | -4.88 | -5.09 | -4.33 | -3.01 | -0.21 | -2.08 | |
| Unlevered Free Cash Flow | -4.88 | -5.09 | -4.33 | -3.01 | -0.21 | -2.08 | |
| Change in Working Capital | -0.42 | 0.28 | 1.01 | 1.25 | 0.14 | -0.8 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.